Almirall Prodesfarma Key Drug Trials Disappoint Investors
9/3/2008 6:38:02 AM
More...
|
Almirall Prodesfarma and Proteros biostructures GmbH Announce Successful Achievement of Key Scientific Milestone in Structural Biology Collaboration
7/24/2008 8:58:40 AM
More...
|
Forest Laboratories, Inc. (FRX) and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
5/21/2008 7:44:43 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY) Sells Medicines to Almirall Prodesfarma for $213 Million
10/8/2007 6:23:10 AM
More...
|
Sareum Ltd. (SAR.L) Release: Extension Of Collaboration With Almirall Prodesfarma
7/13/2006 4:52:41 PM
More...
|
Forest Laboratories, Inc. (FRX) And Almirall Announce A Development And Marketing Collaboration Agreement On New Therapy For COPD
4/10/2006 11:19:29 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Licensing Agreement With Almirall Prodesfarma For Parkinson's Disease
10/19/2005 5:12:09 PM
More...
|
Evotec Enters Into Long-Term Focused Library Agreement With Evotec OAI (United Kingdom)
10/19/2005 5:11:57 PM
More...
|
Dainippon Pharmaceutical , Meiji Seika Kaisha, Ltd. Jointly Market New Formulations For Ebastel Antiallergic Agent
10/19/2005 5:09:29 PM
More...
|